GTCM
EW icon

Gyon Technologies Capital Management’s Edwards Lifesciences EW Stock Holding History

Gyon Technologies Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,251
Closed -$269K – 522
2022
Q3 		$269K Buy
+3,251
New +$313K 0.08% 293
2022
Q1 		– Sell
-2,307
Closed -$299K – 360
2021
Q4 		$299K Sell
2,307
-231
-9% -$26.9K 0.06% 422
2021
Q3 		$287K Buy
+2,538
New +$290K 0.08% 298

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gyon Technologies Capital Management's EW Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 3,251 shares — an estimated $269K sold.

Gyon Technologies Capital Management first reported a position in EW in Q3 2021 and held it in 3 quarters. The position peaked at $299K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Gyon Technologies Capital Management reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 3,251 Edwards Lifesciences shares in Q4 2022, an estimated $269K.
  • Gyon Technologies Capital Management first reported a position in Edwards Lifesciences in Q3 2021 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Edwards Lifesciences position peaked at $299K in Q4 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.